LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=md67ae28b95eadc641a006692e629986d

OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Identify the differences in acceptance criteria fo ECD kidney in the European and US settings. (2) Describe the policies of DKT acceptance based on histological and clinical parameters. (3) Analyze the role of DKT in expanding the utilization of ECD. 

FACULTY DISCLOSURE: Lucrezia Furian, MD is a speaker for Hansa Biopharma, Alexion, Novaris Companies.

PLANNER DISCLOSURE: Robert Goldstein, MD, Sumeet Asrani, MD, and Kathy Brown, RN, CCTC, have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC: Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

CEPTC Credit: The American Board for Transplant Certification (ABTC) has been applied for educational offering for up to 1 Category 1 Continuing Education Point for Transplant Certification (CEPTCs).

For information, please contact Karina Pena at karina.pena@bswhealth.org